Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 2;68(1):36.
doi: 10.1007/s12016-025-09049-y.

Maternal Immune Activation: Implications for Congenital Heart Defects

Affiliations
Review

Maternal Immune Activation: Implications for Congenital Heart Defects

Sixing Wang et al. Clin Rev Allergy Immunol. .

Abstract

Congenital heart defects (CHD) are the most common major birth defects and one of the leading causes of death from congenital defects after birth. CHD can arise in pregnancy from the combination of genetic and non-genetic factors. The maternal immune activation (MIA) hypothesis is widely implicated in embryonic neurodevelopmental abnormalities. MIA has been found to be associated with the development of asthma, diabetes mellitus, and other diseases in the offspring. Given the important role of cardiac immune cells and cytokines in embryonic heart development, it is hypothesized that MIA may play a significant role in embryonic heart development. This review aims to stimulate further investigation into the relationship between MIA and CHD and to highlight the gaps in the knowledge. It evaluates the impact of MIA on CHD in the context of pregnancy complications, immune-related diseases, infections, and environmental and lifestyle factors. The review outlines the mechanisms by which immune cells and their secretome indirectly regulate the immuno-microenvironment of the embryonic heart by influencing placental development. Furthermore, the inflammatory cytokines cross the placenta to induce related reactions including oxidative stress in the embryonic heart directly. This review delineates the role of MIA in CHD and underscores the impact of maternal factors, especially immune factors, as well as the embryonic cardiac immuno-microenvironment, on embryonic heart development. This review extends our understanding of the importance of MIA in the pathogenesis of CHD and provides important insights into prenatal prevention and treatment strategies for this congenital condition.

Keywords: Congenital heart defects; Embryonic cardiac immuno-microenvironment; Embryonic heart development; Maternal immune activation; Pregnancy complication.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of Interest: The authors declare no competing interests.

References

    1. Pan M, Li D-Z (2023) Placenta insufficiency and congenital heart defects. American Journal of Obstetrics & Gynecology MFM 5:101070. https://doi.org/10.1016/j.ajogmf.2023.101070 - DOI
    1. Zhao L, Chen L, Yang T et al (2020) Birth prevalence of congenital heart disease in China, 1980–2019: a systematic review and meta-analysis of 617 studies. Eur J Epidemiol 35:631–642. https://doi.org/10.1007/s10654-020-00653-0 - DOI - PubMed - PMC
    1. Su Z, Zou Z, Hay SI et al (2022) Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study. EClinicalMedicine 43:101249. https://doi.org/10.1016/j.eclinm.2021.101249 - DOI - PubMed - PMC
    1. Zaidi S, Brueckner M (2017) Genetics and genomics of congenital heart disease. Circ Res 120:923–940. https://doi.org/10.1161/CIRCRESAHA.116.309140 - DOI - PubMed - PMC
    1. Feng Y, Cai J, Tong X et al (2018) Non-inheritable risk factors during pregnancy for congenital heart defects in offspring: a matched case-control study. Int J Cardiol 264:45–52. https://doi.org/10.1016/j.ijcard.2018.04.003 - DOI - PubMed

LinkOut - more resources